Xuechao Xing

Person

Wilmington, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 12,145,942
- Issue date Nov 19, 2024
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,976,084
- Issue date May 7, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,958,879
- Issue date Apr 16, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as anti-viral agents
- Patent number 11,945,824
- Issue date Apr 2, 2024
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,919,910
- Issue date Mar 5, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,718,641
- Issue date Aug 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 11,555,032
- Issue date Jan 17, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as anti-viral agents
- Patent number 11,420,976
- Issue date Aug 23, 2022
- Enanta Pharmaceuticals, Inc.
- Yong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,384,090
- Issue date Jul 12, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,352,363
- Issue date Jun 7, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,345,699
- Issue date May 31, 2022
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,325,916
- Issue date May 10, 2022
- Enanta Pharmaceuticals, Inc.
- Ruichao Shen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,040,998
- Issue date Jun 22, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 11,034,684
- Issue date Jun 15, 2021
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,008,304
- Issue date May 18, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,988,458
- Issue date Apr 27, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,968,249
- Issue date Apr 6, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonyl carbamate bile acid derivatives
- Patent number 10,961,272
- Issue date Mar 30, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,829,486
- Issue date Nov 10, 2020
- Enanta Pharmacueticals, Inc.
- Ruichao Shen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,696,713
- Issue date Jun 30, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,689,391
- Issue date Jun 23, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,683,279
- Issue date Jun 16, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonyl carbamate bile acid derivatives
- Patent number 10,676,500
- Issue date Jun 9, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Urea-containing isoxazole derivatives as FXR agonists and methods o...
- Patent number 10,597,391
- Issue date Mar 24, 2020
- Enanta Pharmaceuticals, Inc.
- Jing He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,519,191
- Issue date Dec 31, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR agonists and methods of use thereof
- Patent number 10,472,386
- Issue date Nov 12, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,457,703
- Issue date Oct 29, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Covalent Inhibitors As Antiviral Agents
- Publication number 20240327334
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Xuri GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20240327452
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
- Publication number 20240207224
- Publication date Jun 27, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240140984
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230331734
- Publication date Oct 19, 2023
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230203048
- Publication date Jun 29, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...
- Publication number 20230143250
- Publication date May 11, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230122228
- Publication date Apr 20, 2023
- Enanta Pharmaceuticals, Inc.
- Ruichao Shen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230103494
- Publication date Apr 6, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20220402966
- Publication date Dec 22, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20220356167
- Publication date Nov 10, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20220162216
- Publication date May 26, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20220162217
- Publication date May 26, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20220162231
- Publication date May 26, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20220119366
- Publication date Apr 21, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS
- Publication number 20220119398
- Publication date Apr 21, 2022
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20210261600
- Publication date Aug 26, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS
- Publication number 20210238188
- Publication date Aug 5, 2021
- Enanta Pharmaceuticals, Inc.
- Yong He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200361920
- Publication date Nov 19, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200347092
- Publication date Nov 5, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200331890
- Publication date Oct 22, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYL CARBAMATE BILE ACID DERIVATIVES
- Publication number 20200317717
- Publication date Oct 8, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200157095
- Publication date May 21, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200109164
- Publication date Apr 9, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200079764
- Publication date Mar 12, 2020
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190337923
- Publication date Nov 7, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY

Xuechao Xing

Person

Patents Grantslast 30 patents

Spiropyrrolidine derived antiviral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Spiropyrrolidine derived antiviral agents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Heterocyclic compounds as anti-viral agents

Spiropyrrolidine derived antiviral agents

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Heterocyclic compounds as anti-viral agents

Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Spiropyrrolidine derived antiviral agents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Process for preparation of sulfonyl carbamate bile acid derivatives

Isoxazole derivatives as FXR agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Process for preparation of sulfonyl carbamate bile acid derivatives

Urea-containing isoxazole derivatives as FXR agonists and methods o...

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Bile acid derivatives as FXR agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

Covalent Inhibitors As Antiviral Agents

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS

ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

PROCESS FOR PREPARATION OF SULFONYL CARBAMATE BILE ACID DERIVATIVES

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...